| Year |
Citation |
Score |
| 2020 |
Jayakody H, Zarei S, Nguyen H, Dalton J, Chen K, Hudgins L, Day J, Withrow K, Pandya A, Teasley J, Dobyns WB, Mathews KD, Moore SA. Cobblestone Malformation in LAMA2 Congenital Muscular Dystrophy (MDC1A). Journal of Neuropathology and Experimental Neurology. PMID 32827036 DOI: 10.1093/Jnen/Nlaa062 |
0.322 |
|
| 2020 |
Nix JS, Moore SA. What Every Neuropathologist Needs to Know: The Muscle Biopsy. Journal of Neuropathology and Experimental Neurology. PMID 32529201 DOI: 10.1093/Jnen/Nlaa046 |
0.333 |
|
| 2020 |
Saylam E, Moore SA, Aravindhan A, Marton H, Nagy PL, Gokden M, Cox MO, Stefans V, Veerapandiyan A. A novel noncoding mutation in early onset limb-girdle muscular dystrophy. Neurology. Genetics. 6: e388. PMID 32042916 DOI: 10.1212/Nxg.0000000000000388 |
0.389 |
|
| 2019 |
Earle AJ, Kirby TJ, Fedorchak GR, Isermann P, Patel J, Iruvanti S, Moore SA, Bonne G, Wallrath LL, Lammerding J. Mutant lamins cause nuclear envelope rupture and DNA damage in skeletal muscle cells. Nature Materials. PMID 31844279 DOI: 10.1038/S41563-019-0563-5 |
0.353 |
|
| 2019 |
Bhatia A, Mobley BC, Cogan J, Koziura ME, Brokamp E, Phillips J, Newman J, Moore SA, Hamid R. Magnetic Resonance Imaging characteristics in case of TOR1AIP1 muscular dystrophy. Clinical Imaging. 58: 108-113. PMID 31299614 DOI: 10.1016/J.Clinimag.2019.06.010 |
0.374 |
|
| 2019 |
Lee AJ, Jones KA, Butterfield RJ, Cox MO, Konersman CG, Grosmann C, Abdenur JE, Boyer M, Beson B, Wang C, Dowling JJ, Gibbons MA, Ballard A, Janas JS, Leshner RT, ... ... Moore SA, et al. Clinical, genetic, and pathologic characterization of Mexican founder mutation c.1387A>G. Neurology. Genetics. 5: e315. PMID 31041397 DOI: 10.1212/Nxg.0000000000000315 |
0.713 |
|
| 2019 |
Liewluck T, Niu Z, Moore SA, Alsharabati M, Milone M. ACTA1-myopathy with prominent finger flexor weakness and rimmed vacuoles. Neuromuscular Disorders : Nmd. PMID 30987788 DOI: 10.1016/J.Nmd.2019.02.012 |
0.376 |
|
| 2019 |
Locht Mvd, Winter Jd, Conijn S, Ma W, Helmes M, Irving T, Donkervoort S, Mohassel P, Medne L, Quinn C, Neto O, Moore S, Foley A, Pinto J, Voermans N, et al. P.163Mutations in fast skeletal troponin C (TNNC2) cause contractile dysfunction Neuromuscular Disorders. 29. DOI: 10.1016/J.Nmd.2019.06.218 |
0.304 |
|
| 2018 |
Chandran S, Suggs JA, Wang BJ, Han A, Bhide S, Cryderman DE, Moore SA, Bernstein SI, Wallrath LL, Melkani GC. Suppression of myopathic lamin mutations by muscle-specific activation of AMPK and modulation of downstream signaling. Human Molecular Genetics. PMID 30239736 DOI: 10.1093/Hmg/Ddy332 |
0.37 |
|
| 2018 |
Aeffner F, Faelan C, Moore SA, Moody A, Black JC, Charleston JS, Frank DE, Dworzak J, Piper JK, Ranjitkar M, Wilson K, Kanaly S, Rudmann DG, Lange H, Young GD, et al. Validation of a Muscle-Specific Tissue Image-Analysis Tool for Quantitative Assessment of Dystrophin Staining in Frozen Muscle Biopsies. Archives of Pathology & Laboratory Medicine. PMID 30168727 DOI: 10.5858/Arpa.2017-0536-Oa |
0.339 |
|
| 2018 |
Conant A, Curiel J, Pizzino A, Sabetrasekh P, Murphy J, Bloom M, Evans SH, Helman G, Taft RJ, Simons C, Whitehead MT, Moore SA, Vanderver A. Absence of Axoglial Paranodal Junctions in a Child With CNTNAP1 Mutations, Hypomyelination, and Arthrogryposis. Journal of Child Neurology. 883073818776157. PMID 29882456 DOI: 10.1177/0883073818776157 |
0.326 |
|
| 2018 |
Larson AA, Baker PR, Milev MP, Press CA, Sokol RJ, Cox MO, Lekostaj JK, Stence AA, Bossler AD, Mueller JM, Prematilake K, Tadjo TF, Williams CA, Sacher M, Moore SA. TRAPPC11 and GOSR2 mutations associate with hypoglycosylation of α-dystroglycan and muscular dystrophy. Skeletal Muscle. 8: 17. PMID 29855340 DOI: 10.1186/S13395-018-0163-0 |
0.325 |
|
| 2018 |
Brun BN, Willer T, Darbro BW, Gonorazky HD, Naumenko S, Dowling JJ, Campbell KP, Moore SA, Mathews KD. Uniparental disomy unveils a novel recessive mutation in POMT2. Neuromuscular Disorders : Nmd. PMID 29759639 DOI: 10.1016/J.Nmd.2018.04.003 |
0.377 |
|
| 2018 |
Martinez-Thompson JM, Moore SA, Liewluck T. A novel CAPN3 mutation in late-onset limb-girdle muscular dystrophy with early respiratory insufficiency. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. PMID 29685414 DOI: 10.1016/J.Jocn.2018.04.025 |
0.325 |
|
| 2017 |
Wilson K, Faelan C, Patterson-Kane JC, Rudmann DG, Moore SA, Frank D, Charleston J, Tinsley J, Young GD, Milici AJ. Duchenne and Becker Muscular Dystrophies: A Review of Animal Models, Clinical End Points, and Biomarker Quantification. Toxicologic Pathology. 192623317734823. PMID 28974147 DOI: 10.1177/0192623317734823 |
0.323 |
|
| 2017 |
Dean M, Rashid S, Kupsky W, Moore SA, Jiang H. Child Neurology: LAMA2 muscular dystrophy without contractures. Neurology. 88: e199-e203. PMID 28533353 DOI: 10.1212/Wnl.0000000000003958 |
0.356 |
|
| 2017 |
Donkervoort S, Chan SHS, Hayes LH, Bradley N, Nguyen D, Leach ME, Mohassel P, Hu Y, Thangarajh M, Bharucha-Goebel D, Kan A, Ho RSL, Reyes CA, Nance J, Moore SA, et al. Cytoplasmic body pathology in severe ACTA1-related myopathy in the absence of typical nemaline rods. Neuromuscular Disorders : Nmd. PMID 28416349 DOI: 10.1016/J.Nmd.2017.02.012 |
0.361 |
|
| 2017 |
Shaw ND, Brand H, Kupchinsky ZA, Bengani H, Plummer L, Jones TI, Erdin S, Williamson KA, Rainger J, Stortchevoi A, Samocha K, Currall BB, Dunican DS, Collins RL, Willer JR, ... ... Moore SA, et al. SMCHD1 mutations associated with a rare muscular dystrophy can also cause isolated arhinia and Bosma arhinia microphthalmia syndrome. Nature Genetics. PMID 28067909 DOI: 10.1038/Ng.3743 |
0.32 |
|
| 2016 |
Lawlor MW, Beggs AH, Buj-Bello A, Childers MK, Dowling JJ, James ES, Meng H, Moore SA, Prasad S, Schoser B, Sewry CA. Skeletal Muscle Pathology in X-Linked Myotubular Myopathy: Review With Cross-Species Comparisons. Journal of Neuropathology and Experimental Neurology. PMID 26823526 DOI: 10.1093/Jnen/Nlv020 |
0.345 |
|
| 2015 |
Jensen BS, Willer T, Saade DN, Cox MO, Mozaffar T, Scavina M, Stefans VA, Winder TL, Campbell KP, Moore SA, Mathews KD. Gmppb-Associated Dystroglycanopathy: Emerging Common Variants with Phenotype Correlation. Human Mutation. PMID 26310427 DOI: 10.1002/Humu.22898 |
0.313 |
|
| 2015 |
Brennan KM, Bai Y, Pisciotta C, Wang S, Feely SM, Hoegger M, Gutmann L, Moore SA, Gonzalez M, Sherman DL, Brophy PJ, Züchner S, Shy ME. Absence of Dystrophin Related Protein-2 disrupts Cajal bands in a patient with Charcot-Marie-Tooth disease. Neuromuscular Disorders : Nmd. PMID 26227883 DOI: 10.1016/J.Nmd.2015.07.001 |
0.312 |
|
| 2015 |
Dialynas G, Shrestha OK, Ponce JM, Zwerger M, Thiemann DA, Young GH, Moore SA, Yu L, Lammerding J, Wallrath LL. Myopathic lamin mutations cause reductive stress and activate the nrf2/keap-1 pathway. Plos Genetics. 11: e1005231. PMID 25996830 DOI: 10.1371/Journal.Pgen.1005231 |
0.36 |
|
| 2015 |
Jerath NU, Crockett CD, Moore SA, Shy ME, Weihl CC, Chou TF, Grider T, Gonzalez MA, Zuchner S, Swenson A. Rare Manifestation of a c.290 C>T, p.Gly97Glu VCP Mutation. Case Reports in Genetics. 2015: 239167. PMID 25878907 DOI: 10.1155/2015/239167 |
0.322 |
|
| 2015 |
Al-Zaidy SA, Malik V, Kneile K, Rosales XQ, Gomez AM, Lewis S, Hashimoto S, Gastier-Foster J, Kang P, Darras B, Kunkel L, Carlo J, Sahenk Z, Moore SA, Pyatt R, et al. A slowly progressive form of limb-girdle muscular dystrophy type 2C associated with founder mutation in the SGCG gene in Puerto Rican Hispanics. Molecular Genetics & Genomic Medicine. 3: 92-8. PMID 25802879 DOI: 10.1002/Mgg3.125 |
0.331 |
|
| 2015 |
Dowling JJ, Moore SA, Kalimo H, Minassian BA. X-linked myopathy with excessive autophagy: a failure of self-eating. Acta Neuropathologica. 129: 383-90. PMID 25644398 DOI: 10.1007/S00401-015-1393-4 |
0.352 |
|
| 2015 |
Sanmaneechai O, Swenson A, Gerke AK, Moore SA, Shy ME. Inclusion body myositis and sarcoid myopathy: coincidental occurrence or associated diseases. Neuromuscular Disorders : Nmd. 25: 297-300. PMID 25599912 DOI: 10.1016/J.Nmd.2014.12.005 |
0.325 |
|
| 2015 |
Tsuda T, Fitzgerald K, Scavena M, Gidding S, Cox MO, Marks H, Flanigan KM, Moore SA. Early-progressive dilated cardiomyopathy in a family with Becker muscular dystrophy related to a novel frameshift mutation in the dystrophin gene exon 27. Journal of Human Genetics. 60: 151-5. PMID 25537791 DOI: 10.1038/Jhg.2014.112 |
0.324 |
|
| 2014 |
Inamori K, Willer T, Hara Y, Venzke D, Anderson ME, Clarke NF, Guicheney P, Bönnemann CG, Moore SA, Campbell KP. Endogenous glucuronyltransferase activity of LARGE or LARGE2 required for functional modification of α-dystroglycan in cells and tissues. The Journal of Biological Chemistry. 289: 28138-48. PMID 25138275 DOI: 10.1074/Jbc.M114.597831 |
0.304 |
|
| 2014 |
Bushby K, Finkel R, Wong B, Barohn R, Campbell C, Comi GP, Connolly AM, Day JW, Flanigan KM, Goemans N, Jones KJ, Mercuri E, Quinlivan R, Renfroe JB, Russman B, ... ... Moore SA, et al. Ataluren treatment of patients with nonsense mutation dystrophinopathy. Muscle & Nerve. 50: 477-87. PMID 25042182 DOI: 10.1002/Mus.24332 |
0.321 |
|
| 2014 |
Wallace SE, Conta JH, Winder TL, Willer T, Eskuri JM, Haas R, Patterson K, Campbell KP, Moore SA, Gospe SM. A novel missense mutation in POMT1 modulates the severe congenital muscular dystrophy phenotype associated with POMT1 nonsense mutations. Neuromuscular Disorders : Nmd. 24: 312-20. PMID 24491487 DOI: 10.1016/J.Nmd.2014.01.001 |
0.318 |
|
| 2014 |
Crockett CD, Ruggieri A, Gujrati M, Zallek CM, Ramachandran N, Minassian BA, Moore SA. Late adult-onset of X-linked myopathy with excessive autophagy. Muscle & Nerve. 50: 138-44. PMID 24488655 DOI: 10.1002/Mus.24197 |
0.332 |
|
| 2014 |
Chauveau C, Bonnemann CG, Julien C, Kho AL, Marks H, Talim B, Maury P, Arne-Bes MC, Uro-Coste E, Alexandrovich A, Vihola A, Schafer S, Kaufmann B, Medne L, Hübner N, ... ... Moore SA, et al. Recessive TTN truncating mutations define novel forms of core myopathy with heart disease. Human Molecular Genetics. 23: 980-91. PMID 24105469 DOI: 10.1093/Hmg/Ddt494 |
0.331 |
|
| 2014 |
Bharucha-Goebel DX, Neil E, Donkervoort S, Moore S, Winder T, Dastgir J, Iannaccone S, Bönnemann CG. G.P.312 Neuromuscular Disorders. 24: 915. DOI: 10.1016/J.Nmd.2014.06.402 |
0.353 |
|
| 2014 |
Gutmann L, Gutmann L, Moore S. A.P.13 Neuromuscular Disorders. 24: 834. DOI: 10.1016/J.Nmd.2014.06.143 |
0.358 |
|
| 2014 |
Chauveau C, Bönnemann CG, Julien C, Kho AL, Marks H, Talim B, Maury P, Uro-Coste E, Alexandrovich A, Vihola A, Foley AR, Santi M, Udd B, Topaloglu H, Moore SA, et al. G.P.34 Neuromuscular Disorders. 24: 804-805. DOI: 10.1016/J.Nmd.2014.06.048 |
0.317 |
|
| 2013 |
Nguyen H, Ostendorf AP, Satz JS, Westra S, Ross-Barta SE, Campbell KP, Moore SA. Glial scaffold required for cerebellar granule cell migration is dependent on dystroglycan function as a receptor for basement membrane proteins. Acta Neuropathologica Communications. 1: 58. PMID 24252195 DOI: 10.1186/2051-5960-1-58 |
0.344 |
|
| 2013 |
Goddeeris MM, Wu B, Venzke D, Yoshida-Moriguchi T, Saito F, Matsumura K, Moore SA, Campbell KP. LARGE glycans on dystroglycan function as a tunable matrix scaffold to prevent dystrophy. Nature. 503: 136-40. PMID 24132234 DOI: 10.1038/Nature12605 |
0.347 |
|
| 2013 |
Yang AC, Ng BG, Moore SA, Rush J, Waechter CJ, Raymond KM, Willer T, Campbell KP, Freeze HH, Mehta L. Congenital disorder of glycosylation due to DPM1 mutations presenting with dystroglycanopathy-type congenital muscular dystrophy. Molecular Genetics and Metabolism. 110: 345-51. PMID 23856421 DOI: 10.1016/J.Ymgme.2013.06.016 |
0.357 |
|
| 2013 |
Carss KJ, Stevens E, Foley AR, Cirak S, Riemersma M, Torelli S, Hoischen A, Willer T, van Scherpenzeel M, Moore SA, Messina S, Bertini E, Bönnemann CG, Abdenur JE, Grosmann CM, et al. Mutations in GDP-mannose pyrophosphorylase B cause congenital and limb-girdle muscular dystrophies associated with hypoglycosylation of α-dystroglycan. American Journal of Human Genetics. 93: 29-41. PMID 23768512 DOI: 10.1016/J.Ajhg.2013.05.009 |
0.362 |
|
| 2013 |
Davidson AE, Siddiqui FM, Lopez MA, Lunt P, Carlson HA, Moore BE, Love S, Born DE, Roper H, Majumdar A, Jayadev S, Underhill HR, Smith CO, von der Hagen M, Hubner A, ... ... Moore SA, et al. Novel deletion of lysine 7 expands the clinical, histopathological and genetic spectrum of TPM2-related myopathies. Brain : a Journal of Neurology. 136: 508-21. PMID 23413262 DOI: 10.1093/Brain/Aws344 |
0.338 |
|
| 2013 |
Cirak S, Foley AR, Herrmann R, Willer T, Yau S, Stevens E, Torelli S, Brodd L, Kamynina A, Vondracek P, Roper H, Longman C, Korinthenberg R, Marrosu G, Nürnberg P, ... ... Moore SA, et al. ISPD gene mutations are a common cause of congenital and limb-girdle muscular dystrophies. Brain : a Journal of Neurology. 136: 269-81. PMID 23288328 DOI: 10.1093/Brain/Aws312 |
0.362 |
|
| 2013 |
Dastgir J, Rutkowski A, Alvarez R, Cossette S, Yan K, Hoffmann R, Sewry C, Hayashi Y, Moore S, Goebel H, Bonnemann C, Lawlor M. P.10.18 Common data elements for muscle biopsy reporting Neuromuscular Disorders. 23: 794. DOI: 10.1016/J.Nmd.2013.06.548 |
0.323 |
|
| 2013 |
Horstick E, Li X, Moore S, Dowling J. P.1.13 Autophagy and the pathogenesis of congenital muscular dystrophies Neuromuscular Disorders. 23: 745. DOI: 10.1016/J.Nmd.2013.06.397 |
0.324 |
|
| 2012 |
Willer T, Lee H, Lommel M, Yoshida-Moriguchi T, de Bernabe DB, Venzke D, Cirak S, Schachter H, Vajsar J, Voit T, Muntoni F, Loder AS, Dobyns WB, Winder TL, Strahl S, ... ... Moore SA, et al. ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome. Nature Genetics. 44: 575-80. PMID 22522420 DOI: 10.1038/Ng.2252 |
0.326 |
|
| 2012 |
Acsadi G, Moore SA, Chéron A, Delalande O, Bennett L, Kupsky W, El-Baba M, Le Rumeur E, Hubert JF. Novel mutation in spectrin-like repeat 1 of dystrophin central domain causes protein misfolding and mild Becker muscular dystrophy. The Journal of Biological Chemistry. 287: 18153-62. PMID 22453924 DOI: 10.1074/Jbc.M111.284521 |
0.327 |
|
| 2012 |
Dialynas G, Flannery KM, Zirbel LN, Nagy PL, Mathews KD, Moore SA, Wallrath LL. LMNA variants cause cytoplasmic distribution of nuclear pore proteins in Drosophila and human muscle. Human Molecular Genetics. 21: 1544-56. PMID 22186027 DOI: 10.1093/Hmg/Ddr592 |
0.369 |
|
| 2012 |
Rocha CT, Taylor M, Chang T, Reyes C, Winder T, Moore S, Bonnemann C, Nelson K. G.P.56 Novel homozygous stop mutation in alphaB crystallin: Expanding the phenotype Neuromuscular Disorders. 22: 821. DOI: 10.1016/J.Nmd.2012.06.066 |
0.366 |
|
| 2012 |
Dowling J, Davidson A, Lopez M, Siddiqui F, Lunt P, Li J, Jungbluth H, Love S, Moore S. D.P.8 Expanding the clinical and genetic phenotype of TPM2-related myopathies Neuromuscular Disorders. 22: 810. DOI: 10.1016/J.Nmd.2012.06.028 |
0.326 |
|
| 2012 |
Willer T, Lee H, Lommel M, Yoshida-Moriguchi T, Beltran Valero de Bernabe D, Venzke D, Cirak S, Schachter H, Vajsar J, Voit T, Muntoni F, Strahl S, Mathews K, Nelson S, Moore S, et al. D.I.4 Patient fibroblast functional complementation studies: A valuable tool in the identification of novel Walker–Warburg syndrome disease genes Neuromuscular Disorders. 22: 805. DOI: 10.1016/J.Nmd.2012.06.014 |
0.333 |
|
| 2011 |
Di Blasi C, Bellafiore E, Salih MA, Manzini MC, Moore SA, Seidahmed MZ, Mukhtar MM, Karrar ZA, Walsh CA, Campbell KP, Mantegazza R, Morandi L, Mora M. Variable disease severity in Saudi Arabian and Sudanese families with c.3924 + 2 T > C mutation of LAMA2. Bmc Research Notes. 4: 534. PMID 22166137 DOI: 10.1186/1756-0500-4-534 |
0.33 |
|
| 2011 |
Mathews KD, Stephan CM, Laubenthal K, Winder TL, Michele DE, Moore SA, Campbell KP. Myoglobinuria and muscle pain are common in patients with limb-girdle muscular dystrophy 2I. Neurology. 76: 194-5. PMID 21220724 DOI: 10.1212/Wnl.0B013E3182061Ad4 |
0.349 |
|
| 2010 |
Han R, Frett EM, Levy JR, Rader EP, Lueck JD, Bansal D, Moore SA, Ng R, Beltrán-Valero de Bernabé D, Faulkner JA, Campbell KP. Genetic ablation of complement C3 attenuates muscle pathology in dysferlin-deficient mice. The Journal of Clinical Investigation. 120: 4366-74. PMID 21060153 DOI: 10.1172/Jci42390 |
0.365 |
|
| 2010 |
Satz JS, Ostendorf AP, Hou S, Turner A, Kusano H, Lee JC, Turk R, Nguyen H, Ross-Barta SE, Westra S, Hoshi T, Moore SA, Campbell KP. Distinct functions of glial and neuronal dystroglycan in the developing and adult mouse brain. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 14560-72. PMID 20980614 DOI: 10.1523/Jneurosci.3247-10.2010 |
0.314 |
|
| 2010 |
Guo LT, Moore SA, Forcales S, Engvall E, Shelton GD. Evaluation of commercial dysferlin antibodies on canine, mouse and human skeletal muscle. Neuromuscular Disorders : Nmd. 20: 820-5. PMID 20817457 DOI: 10.1016/J.Nmd.2010.07.278 |
0.325 |
|
| 2010 |
Trantow CM, Hedberg-Buenz A, Iwashita S, Moore SA, Anderson MG. Elevated oxidative membrane damage associated with genetic modifiers of Lyst-mutant phenotypes. Plos Genetics. 6: e1001008. PMID 20617205 DOI: 10.1371/Journal.Pgen.1001008 |
0.304 |
|
| 2009 |
Wakefield SE, Dimberg EL, Moore SA, Tseng BS. Dystrophinopathy presenting with arrhythmia in an asymptomatic 34-year-old man: a case report. Journal of Medical Case Reports. 3: 8625. PMID 19830234 DOI: 10.4076/1752-1947-3-8625 |
0.306 |
|
| 2009 |
Margeta M, Connolly AM, Winder TL, Pestronk A, Moore SA. Cardiac pathology exceeds skeletal muscle pathology in two cases of limb-girdle muscular dystrophy type 2I. Muscle & Nerve. 40: 883-9. PMID 19705481 DOI: 10.1002/Mus.21432 |
0.345 |
|
| 2009 |
Han R, Kanagawa M, Yoshida-Moriguchi T, Rader EP, Ng RA, Michele DE, Muirhead DE, Kunz S, Moore SA, Iannaccone ST, Miyake K, McNeil PL, Mayer U, Oldstone MB, Faulkner JA, et al. Basal lamina strengthens cell membrane integrity via the laminin G domain-binding motif of alpha-dystroglycan. Proceedings of the National Academy of Sciences of the United States of America. 106: 12573-9. PMID 19633189 DOI: 10.1073/Pnas.0906545106 |
0.339 |
|
| 2009 |
Puckett RL, Moore SA, Winder TL, Willer T, Romansky SG, Covault KK, Campbell KP, Abdenur JE. Further evidence of Fukutin mutations as a cause of childhood onset limb-girdle muscular dystrophy without mental retardation. Neuromuscular Disorders : Nmd. 19: 352-6. PMID 19342235 DOI: 10.1016/J.Nmd.2009.03.001 |
0.352 |
|
| 2008 |
Satz JS, Barresi R, Durbeej M, Willer T, Turner A, Moore SA, Campbell KP. Brain and eye malformations resembling Walker-Warburg syndrome are recapitulated in mice by dystroglycan deletion in the epiblast. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 10567-75. PMID 18923033 DOI: 10.1523/Jneurosci.2457-08.2008 |
0.317 |
|
| 2008 |
Pace RA, Peat RA, Baker NL, Zamurs L, Mörgelin M, Irving M, Adams NE, Bateman JF, Mowat D, Smith NJ, Lamont PJ, Moore SA, Mathews KD, North KN, Lamandé SR. Collagen VI glycine mutations: perturbed assembly and a spectrum of clinical severity. Annals of Neurology. 64: 294-303. PMID 18825676 DOI: 10.1002/Ana.21439 |
0.302 |
|
| 2008 |
Spuler S, Carl M, Zabojszcza J, Straub V, Bushby K, Moore SA, Bähring S, Wenzel K, Vinkemeier U, Rocken C. Dysferlin-deficient muscular dystrophy features amyloidosis. Annals of Neurology. 63: 323-8. PMID 18306167 DOI: 10.1002/Ana.21309 |
0.338 |
|
| 2008 |
Kobuke K, Piccolo F, Garringer KW, Moore SA, Sweezer E, Yang B, Campbell KP. A common disease-associated missense mutation in alpha-sarcoglycan fails to cause muscular dystrophy in mice. Human Molecular Genetics. 17: 1201-13. PMID 18252746 DOI: 10.1093/Hmg/Ddn009 |
0.31 |
|
| 2008 |
Ferraris S, Clark S, Garelli E, Davidzon G, Moore SA, Kardon RH, Bienstock RJ, Longley MJ, Mancuso M, Gutiérrez RÃos P, Hirano M, Copeland WC, DiMauro S. Progressive external ophthalmoplegia and vision and hearing loss in a patient with mutations in POLG2 and OPA1. Archives of Neurology. 65: 125-31. PMID 18195150 DOI: 10.1001/Archneurol.2007.9 |
0.328 |
|
| 2006 |
Moore SA, Shilling CJ, Westra S, Wall C, Wicklund MP, Stolle C, Brown CA, Michele DE, Piccolo F, Winder TL, Stence A, Barresi R, King N, King W, Florence J, et al. Limb-girdle muscular dystrophy in the United States. Journal of Neuropathology and Experimental Neurology. 65: 995-1003. PMID 17021404 DOI: 10.1097/01.Jnen.0000235854.77716.6C |
0.328 |
|
| 2005 |
Collins XH, Harmon SD, Kaduce TL, Berst KB, Fang X, Moore SA, Raju TV, Falck JR, Weintraub NL, Duester G, Plapp BV, Spector AA. Omega-oxidation of 20-hydroxyeicosatetraenoic acid (20-HETE) in cerebral microvascular smooth muscle and endothelium by alcohol dehydrogenase 4. The Journal of Biological Chemistry. 280: 33157-64. PMID 16081420 DOI: 10.1074/Jbc.M504055200 |
0.325 |
|
| 2004 |
Chen P, Hu S, Harmon SD, Moore SA, Spector AA, Fang X. Metabolism of anandamide in cerebral microvascular endothelial cells. Prostaglandins & Other Lipid Mediators. 73: 59-72. PMID 15165032 DOI: 10.1016/J.Prostaglandins.2003.11.005 |
0.307 |
|
| 2003 |
Mathews KD, Moore SA. Limb-girdle muscular dystrophy. Current Neurology and Neuroscience Reports. 3: 78-85. PMID 12507416 DOI: 10.1007/S11910-003-0042-9 |
0.321 |
|
| 2002 |
Cohn RD, Henry MD, Michele DE, Barresi R, Saito F, Moore SA, Flanagan JD, Skwarchuk MW, Robbins ME, Mendell JR, Williamson RA, Campbell KP. Disruption of DAG1 in differentiated skeletal muscle reveals a role for dystroglycan in muscle regeneration. Cell. 110: 639-48. PMID 12230980 DOI: 10.1016/S0092-8674(02)00907-8 |
0.355 |
|
| 2002 |
Moore SA, Saito F, Chen J, Michele DE, Henry MD, Messing A, Cohn RD, Ross-Barta SE, Westra S, Williamson RA, Hoshi T, Campbell KP. Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy. Nature. 418: 422-5. PMID 12140559 DOI: 10.1038/Nature00838 |
0.354 |
|
| 2002 |
Michele DE, Barresi R, Kanagawa M, Saito F, Cohn RD, Satz JS, Dollar J, Nishino I, Kelley RI, Somer H, Straub V, Mathews KD, Moore SA, Campbell KP. Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Nature. 418: 417-22. PMID 12140558 DOI: 10.1038/Nature00837 |
0.358 |
|
| 2001 |
Katz R, Hamilton JA, Spector AA, Moore SA, Moser HW, Noetzel MJ, Watkins PA. Brain uptake and utilization of fatty acids: recommendations for future research. Journal of Molecular Neuroscience : Mn. 16: 333-5. PMID 11478387 DOI: 10.1385/Jmn:16:2-3:333 |
0.302 |
|
| 2001 |
Moore SA. Polyunsaturated fatty acid synthesis and release by brain-derived cells in vitro. Journal of Molecular Neuroscience : Mn. 16: 195-200; discussion . PMID 11478374 DOI: 10.1385/Jmn:16:2-3:195 |
0.309 |
|
| 2001 |
Cohn RD, Durbeej M, Moore SA, Coral-Vazquez R, Prouty S, Campbell KP. Prevention of cardiomyopathy in mouse models lacking the smooth muscle sarcoglycan-sarcospan complex. The Journal of Clinical Investigation. 107: R1-7. PMID 11160141 DOI: 10.1172/Jci11642 |
0.34 |
|
| 2000 |
Piccolo F, Moore SA, Ford GC, Campbell KP. Intracellular accumulation and reduced sarcolemmal expression of dysferlin in limb--girdle muscular dystrophies. Annals of Neurology. 48: 902-12. PMID 11117547 DOI: 10.1002/1531-8249(200012)48:6<902::Aid-Ana11>3.0.Co;2-Z |
0.373 |
|
| 2000 |
Barresi R, Moore SA, Stolle CA, Mendell JR, Campbell KP. Expression of gamma -sarcoglycan in smooth muscle and its interaction with the smooth muscle sarcoglycan-sarcospan complex. The Journal of Biological Chemistry. 275: 38554-60. PMID 10993904 DOI: 10.1074/Jbc.M007799200 |
0.344 |
|
| 2000 |
Crosbie RH, Lim LE, Moore SA, Hirano M, Hays AP, Maybaum SW, Collin H, Dovico SA, Stolle CA, Fardeau M, Tomé FM, Campbell KP. Molecular and genetic characterization of sarcospan: insights into sarcoglycan-sarcospan interactions. Human Molecular Genetics. 9: 2019-27. PMID 10942431 DOI: 10.1093/Hmg/9.13.2019 |
0.328 |
|
| 2000 |
Durbeej M, Cohn RD, Hrstka RF, Moore SA, Allamand V, Davidson BL, Williamson RA, Campbell KP. Disruption of the beta-sarcoglycan gene reveals pathogenetic complexity of limb-girdle muscular dystrophy type 2E. Molecular Cell. 5: 141-51. PMID 10678176 DOI: 10.1016/S1097-2765(00)80410-4 |
0.345 |
|
| 1999 |
Coral-Vazquez R, Cohn RD, Moore SA, Hill JA, Weiss RM, Davisson RL, Straub V, Barresi R, Bansal D, Hrstka RF, Williamson R, Campbell KP. Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy. Cell. 98: 465-74. PMID 10481911 DOI: 10.1016/S0092-8674(00)81975-3 |
0.347 |
|
| 1998 |
Fang X, Moore SA, Stoll LL, Rich G, Kaduce TL, Weintraub NL, Spector AA. 14,15-Epoxyeicosatrienoic acid inhibits prostaglandin E2 production in vascular smooth muscle cells. The American Journal of Physiology. 275: H2113-21. PMID 9843811 DOI: 10.1152/Ajpheart.1998.275.6.H2113 |
0.349 |
|
| 1998 |
Duclos F, Straub V, Moore SA, Venzke DP, Hrstka RF, Crosbie RH, Durbeej M, Lebakken CS, Ettinger AJ, van der Meulen J, Holt KH, Lim LE, Sanes JR, Davidson BL, Faulkner JA, et al. Progressive muscular dystrophy in alpha-sarcoglycan-deficient mice. The Journal of Cell Biology. 142: 1461-71. PMID 9744877 DOI: 10.1083/Jcb.142.6.1461 |
0.308 |
|
| 1996 |
Rich G, Yoder EJ, Prokuski L, Moore SA. Prostaglandin production in cultured cerebral microvascular smooth muscle is serum dependent. The American Journal of Physiology. 270: C1379-87. PMID 8967438 DOI: 10.1152/Ajpcell.1996.270.5.C1379 |
0.354 |
|
| 1995 |
Simon JS, Baum JS, Moore SA, Kasson BG. Arginine vasopressin stimulates protein synthesis but not proliferation of cultured vascular endothelial cells. Journal of Cardiovascular Pharmacology. 25: 368-75. PMID 7769800 DOI: 10.1097/00005344-199503000-00004 |
0.316 |
|
| 1993 |
Sandor M, Fabry Z, Moore S, Schelper R, Hart M, Lynch R. IgG Fc receptor (R expression on cell lines established from murine brain Journal of Neuroimmunology. 43: 211. DOI: 10.1016/0165-5728(93)90124-H |
0.513 |
|
| 1992 |
Hart MN, Fabry Z, Love-Homan L, Keiner J, Sadewasser KL, Moore SA. Brain microvascular smooth muscle and endothelial cells produce granulocyte macrophage colony-stimulating factor and support colony formation of granulocyte-macrophage-like cells. The American Journal of Pathology. 141: 421-7. PMID 1497093 |
0.517 |
|
| 1992 |
Haddad SF, Moore SA, Schelper RL, Goeken JA. Smooth muscle can comprise the sarcomatous component of gliosarcomas. Journal of Neuropathology and Experimental Neurology. 51: 493-8. PMID 1381414 DOI: 10.1097/00005072-199209000-00003 |
0.353 |
|
| 1992 |
Haddad SF, Moore SA, Schelper RL, Goeken JA. Vascular smooth muscle hyperplasia underlies the formation of glomeruloid vascular structures of glioblastoma multiforme. Journal of Neuropathology and Experimental Neurology. 51: 488-92. PMID 1381413 DOI: 10.1097/00005072-199209000-00002 |
0.324 |
|
| 1990 |
Fabry Z, Waldschmidt MM, Moore SA, Hart MN. Antigen presentation by brain microvessel smooth muscle and endothelium. Journal of Neuroimmunology. 28: 63-71. PMID 2111334 DOI: 10.1016/0165-5728(90)90041-K |
0.551 |
|
| 1990 |
Fabry Z, Waldschmidt MM, Van Dyk L, Moore SA, Hart MN. Activation of CD4+ lymphocytes by syngeneic brain microvascular smooth muscle cells. Journal of Immunology (Baltimore, Md. : 1950). 145: 1099-104. PMID 1974273 |
0.501 |
|
| 1990 |
Sahagun G, Moore SA, Hart MN. Permeability of neutral vs. anionic dextrans in cultured brain microvascular endothelium. The American Journal of Physiology. 259: H162-6. PMID 1695819 DOI: 10.1152/Ajpheart.1990.259.1.H162 |
0.515 |
|
| 1989 |
Sahagun G, Moore SA, Fabry Z, Schelper RL, Hart MN. Purification of murine endothelial cell cultures by flow cytometry using fluorescein-labeled griffonia simplicifolia agglutinin. The American Journal of Pathology. 134: 1227-32. PMID 2757116 |
0.502 |
|
| 1989 |
Moore SA, Figard PH, Spector AA, Hart MN. Brain microvessels produce 12-hydroxyeicosatetraenoic acid. Journal of Neurochemistry. 53: 376-82. PMID 2501450 DOI: 10.1111/J.1471-4159.1989.Tb07345.X |
0.54 |
|
| 1989 |
Moore SA, Figard PH, Spector AA, Hart MN. Eicosanoid production by isolated cerebral microvessels and cultured cerebral endothelium Annals of the New York Academy of Sciences. 559: 471-473. DOI: 10.1111/J.1749-6632.1989.Tb22645.X |
0.518 |
|
| 1989 |
Moore SA, Prokuski LJ, Flugum LA, Hart MN. PROSTAGLANDIN I2 AND E2 PRODUCTION BY CULTURED CEREBROMICROVASCULAR SMOOTH MUSCLE IS DEPENDENT UPON SERUM Journal of Neuropathology and Experimental Neurology. 48: 320. DOI: 10.1097/00005072-198905000-00063 |
0.551 |
|
| 1988 |
Moore SA, Spector AA, Hart MN. Eicosanoid metabolism in cerebromicrovascular endothelium. The American Journal of Physiology. 254: C37-44. PMID 3337219 DOI: 10.1152/Ajpcell.1988.254.1.C37 |
0.554 |
|
| 1988 |
Moore SA, Prokuski LJ, Figard PH, Spector AA, Hart MN. Murine cerebral microvascular endothelium incorporate and metabolize 12-hydroxyeicosatetraenoic acid. Journal of Cellular Physiology. 137: 75-85. PMID 3170659 DOI: 10.1002/Jcp.1041370109 |
0.546 |
|
| 1987 |
Vinters HV, Reave S, Costello P, Girvin JP, Moore SA. Isolation and culture of cells derived from human cerebral microvessels. Cell and Tissue Research. 249: 657-67. PMID 3664609 DOI: 10.1007/Bf00217338 |
0.361 |
|
| 1987 |
Hart MN, Waldschmidt MM, Hanley-Hyde JM, Moore SA, Kemp JD, Schelper RL. Brain microvascular smooth muscle expresses class II antigens. Journal of Immunology (Baltimore, Md. : 1950). 138: 2960-3. PMID 3471815 |
0.514 |
|
| 1987 |
Hart MN, VanDyk LF, Moore SA, Shasby DM, Cancilla PA. Differential opening of the brain endothelial barrier following neutralization of the endothelial luminal anionic charge in vitro. Journal of Neuropathology and Experimental Neurology. 46: 141-53. PMID 2434625 |
0.465 |
|
| 1987 |
Moore SA, Spector AA, Hart MN. 12-HYDROXYEICOSATETRAENOIC ACID IS THE MAJOR METABOLITE OF ARACHIDONIC ACID IN BRAIN MICROVESSELS Journal of Neuropathology and Experimental Neurology. 46: 400. DOI: 10.1097/00005072-198705000-00211 |
0.52 |
|
| 1986 |
Smoker WR, Biller J, Moore SA, Beck DW, Hart MN. Intradural spinal teratoma: case report and review of the literature. Ajnr. American Journal of Neuroradiology. 7: 905-10. PMID 3096113 |
0.421 |
|
| 1985 |
Hart MN, Tassell SK, Sadewasser KL, Schelper RL, Moore SA. Autoimmune vasculitis resulting from in vitro immunization of lymphocytes to smooth muscle. The American Journal of Pathology. 119: 448-55. PMID 4014434 |
0.534 |
|
| 1985 |
Moore SA, Evan AP, Miller BG, Bohlen HG. Cellular and vessel wall morphology of cerebral cortical arterioles after short-term diabetes in adult rats Journal of Vascular Research. 22: 265-277. DOI: 10.1159/000158613 |
0.305 |
|
| 1985 |
Moore SA, Roberts R, VdflDyki L, Hart MN. CEREBRAL TRANSENDOTHELIAL ELECTRICAL RESISTANCE IN VITRO Journal of Neuropathology and Experimental Neurology. 44: 340. DOI: 10.1097/00005072-198505000-00109 |
0.489 |
|
| 1984 |
Moore SA, Strauch AR, Yoder EJ, Rubenstein PA, Hart MN. Cerebral microvascular smooth muscle in tissue culture. In Vitro. 20: 512-20. PMID 6235174 DOI: 10.1007/Bf02619625 |
0.585 |
|
| 1984 |
Beck DW, Vinters HV, Moore SA, Hart MN, Henn FA, Cancilla PA. Demonstration of adenosine receptors on mouse cerebral smooth muscle membranes. Stroke; a Journal of Cerebral Circulation. 15: 725-7. PMID 6087502 DOI: 10.1161/01.Str.15.4.725 |
0.552 |
|
| 1983 |
Beck DW, Vinters HV, Moore SA, Hart MN, Cancilla PA. Uptake of adenosine by cultured cerebral vascular smooth muscle cells. Journal of Neurochemistry. 41: 939-41. PMID 6619860 DOI: 10.1111/J.1471-4159.1983.Tb09037.X |
0.575 |
|
| Show low-probability matches. |
